Evidence map›Paper›PMID 18474041›Full record

ReviewBioTechniques2008

Resolving the network of cell signaling pathways using the evolving yeast two-hybrid system.

Vladimir Ratushny, Erica Golemis

Open access · goldAbstract readReview
In one paragraph

Review in BioTechniques, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. Backstage Heroes-Yeast in COVID-19 Research.International journal of molecular sciences · 2024
    Review
  2. A High-ThroughputmSphere · 2018
    Article
  3. Review
  4. Article
  5. Murine cytomegalovirus IE3 protein interacts with Ankrd17.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2011
    Article
  6. Article
  7. Article
  8. Mechanisms of tumor resistance to EGFR-targeted therapies.Expert opinion on therapeutic targets · 2009
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vladimir RatushnyFox Chase Cancer Center, Philadelphia, PA 19111, USA.
Erica Golemis
Drexel University · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
ROLES OF HEF1 IN CELL DIFFERENTIATION AND SURVIVALR01CA063366 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI GOLEMIS, ERICA A. · 1998 to 2013
$3.9M
Cas Protein Regulation of EMT in CancerR01CA113342 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI GOLEMIS, ERICA A. · 2007 to 2011
$1.5M
CONTROL OF NORMAL AND ABNORMAL CELL GROWTHR29CA063366 · NCI · INSTITUTE FOR CANCER RESEARCH · PI GOLEMIS, ERICA A · 1994 to 1997
–
NCI NIH HHS CA-06927NCI NIH HHS CA113342NCI NIH HHS CA63366NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA063366NCI NIH HHS R01 CA113342
6 · The paper itself

Abstract

In 1983, while investigators had identified a few human proteins as important regulators of specific biological outcomes, how these proteins acted in the cell was essentially unknown in almost all cases. Twenty-five years later, our knowledge of the mechanistic basis of protein action has been transformed by our increasingly detailed understanding of protein-protein interactions, which have allowed us to define cellular machines. The advent of the yeast two-hybrid (Y2H) system in 1989 marked a milestone in the field of proteomics. Exploiting the modular nature of transcription factors, the Y2H system allows facile measurement of the activation of reporter genes based on interactions between two chimeric or "hybrid" proteins of interest. After a decade of service as a leading platform for individual investigators to use in exploring the interaction properties of interesting target proteins, the Y2H system has increasingly been applied in high-throughput applications intended to map genome-scale protein-protein interactions for model organisms and humans. Although some significant technical limitations apply, Y2H has made a great contribution to our general understanding of the topology of cellular signaling networks.

Indexed as

Gene Expression ProfilingProtein Interaction MappingProteomeSignal TransductionTwo-Hybrid System TechniquesProteome

Identifiers

PMID18474041
PMCPMC2526548
OpenAlexW2094475562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.